In addition, there are currently some drugs on the market that act as ferroptosis inducers (such as Sulfasalazine, a clinically used drug for the treatment of chronic inflammatory diseases, which can target SLC7A11 to induce ferroptosis in cancer cells). This evidence concerns the gene SLC7A11 and cancer.